Addus HomeCare Corporation (ADUS)
USD 129.75
(-0.75%)
USD 129.75
(-0.75%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 106.55 Million USD | 34.06% |
| 2022 | 83.13 Million USD | 2.94% |
| 2021 | 80.69 Million USD | 42.21% |
| 2020 | 57.18 Million USD | 20.72% |
| 2019 | 46.84 Million USD | 31.71% |
| 2018 | 35.53 Million USD | 15.8% |
| 2017 | 33.18 Million USD | 23.37% |
| 2016 | 24.9 Million USD | 20.05% |
| 2015 | 20.78 Million USD | -5.3% |
| 2014 | 21.91 Million USD | 24.29% |
| 2013 | 17.8 Million USD | -1.25% |
| 2012 | 18.33 Million USD | 1.38% |
| 2011 | 1.61 Million USD | 9.75% |
| 2010 | 16.03 Million USD | -3.9% |
| 2009 | 16.68 Million USD | -1.78% |
| 2008 | 16.99 Million USD | 51.57% |
| 2007 | 11.21 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 28.5 Million USD | 4.16% |
| 2024 Q1 | 27.53 Million USD | -19.62% |
| 2024 Q2 | 29.58 Million USD | 9.15% |
| 2023 Q3 | 26.45 Million USD | 6.17% |
| 2023 Q2 | 24.92 Million USD | 12.99% |
| 2023 Q4 | 33.64 Million USD | 27.17% |
| 2023 Q1 | 22.05 Million USD | -9.25% |
| 2023 FY | - USD | 34.06% |
| 2022 Q4 | 24.3 Million USD | 15.97% |
| 2022 Q2 | 20.5 Million USD | 19.96% |
| 2022 FY | - USD | 2.94% |
| 2022 Q1 | 17.09 Million USD | -26.51% |
| 2022 Q3 | 20.95 Million USD | 2.21% |
| 2021 Q2 | 20.63 Million USD | 30.84% |
| 2021 Q1 | 15.77 Million USD | 5.88% |
| 2021 FY | - USD | 42.21% |
| 2021 Q3 | 20.76 Million USD | 0.63% |
| 2021 Q4 | 23.25 Million USD | 12.0% |
| 2020 Q4 | 14.89 Million USD | -3.42% |
| 2020 FY | - USD | 20.72% |
| 2020 Q3 | 15.42 Million USD | 16.37% |
| 2020 Q1 | 13.88 Million USD | -19.06% |
| 2020 Q2 | 13.25 Million USD | -4.53% |
| 2019 Q4 | 17.15 Million USD | 70.9% |
| 2019 Q2 | 10.24 Million USD | 23.22% |
| 2019 FY | - USD | 31.71% |
| 2019 Q1 | 8.31 Million USD | -8.33% |
| 2019 Q3 | 10.03 Million USD | -2.07% |
| 2018 Q1 | 8.69 Million USD | -4.16% |
| 2018 Q4 | 9.07 Million USD | 7.53% |
| 2018 FY | - USD | 15.8% |
| 2018 Q3 | 8.43 Million USD | -8.87% |
| 2018 Q2 | 9.25 Million USD | 6.55% |
| 2017 Q1 | 6.47 Million USD | -47.1% |
| 2017 Q4 | 9.06 Million USD | 18.03% |
| 2017 Q3 | 7.68 Million USD | 3.32% |
| 2017 FY | - USD | 23.37% |
| 2017 Q2 | 7.43 Million USD | 14.81% |
| 2016 FY | - USD | 20.05% |
| 2016 Q3 | 4.21 Million USD | -31.31% |
| 2016 Q2 | 6.13 Million USD | 188.03% |
| 2016 Q1 | 2.13 Million USD | -49.59% |
| 2016 Q4 | 12.24 Million USD | 190.37% |
| 2015 Q3 | 5.48 Million USD | -12.43% |
| 2015 FY | - USD | -5.3% |
| 2015 Q4 | 4.22 Million USD | -22.88% |
| 2015 Q2 | 6.25 Million USD | 31.13% |
| 2015 Q1 | 4.77 Million USD | -25.28% |
| 2014 Q1 | 4.26 Million USD | 6.36% |
| 2014 Q2 | 8.49 Million USD | 99.23% |
| 2014 Q3 | 6.06 Million USD | -28.6% |
| 2014 Q4 | 6.38 Million USD | 5.29% |
| 2014 FY | - USD | 24.29% |
| 2013 Q2 | 4.52 Million USD | 5.43% |
| 2013 Q3 | 4.8 Million USD | 6.24% |
| 2013 Q4 | 4.01 Million USD | -16.51% |
| 2013 FY | - USD | -1.25% |
| 2013 Q1 | 4.28 Million USD | -27.47% |
| 2012 Q2 | 3.23 Million USD | 86.36% |
| 2012 FY | - USD | 1.38% |
| 2012 Q4 | 5.91 Million USD | 54.24% |
| 2012 Q1 | 1.73 Million USD | 119.32% |
| 2012 Q3 | 3.83 Million USD | 18.34% |
| 2011 FY | - USD | 9.75% |
| 2011 Q1 | 2.93 Million USD | -32.09% |
| 2011 Q2 | 3.61 Million USD | 23.24% |
| 2011 Q3 | 20.04 Million USD | 454.19% |
| 2011 Q4 | -8.99 Million USD | -144.88% |
| 2010 Q2 | 4.22 Million USD | 16.08% |
| 2010 Q1 | 3.63 Million USD | 79.57% |
| 2010 Q4 | 4.32 Million USD | 12.11% |
| 2010 Q3 | 3.85 Million USD | -8.71% |
| 2010 FY | - USD | -3.9% |
| 2009 Q2 | 5.03 Million USD | 15.88% |
| 2009 Q3 | 5.28 Million USD | 4.85% |
| 2009 FY | - USD | -1.78% |
| 2009 Q4 | 2.02 Million USD | -61.63% |
| 2009 Q1 | 4.34 Million USD | -13.05% |
| 2008 Q4 | 4.99 Million USD | 10.6% |
| 2008 FY | - USD | 51.57% |
| 2008 Q3 | 4.51 Million USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 43.654% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | -276.37% |
| Amedisys, Inc. | 216.91 Million USD | 50.875% |
| American Oncology Network, Inc. | -39.35 Million USD | 370.789% |
| Astrana Health, Inc. | 123.68 Million USD | 13.849% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | -140.277% |
| IMAC Holdings, Inc. | -5.94 Million USD | 1891.856% |
| biote Corp. | 9.23 Million USD | -1053.974% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 1122.896% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 17.611% |
| COMPASS Pathways plc | -123.8 Million USD | 186.071% |
| DocGo Inc. | 32.72 Million USD | -225.615% |
| The Ensign Group, Inc. | 353.23 Million USD | 69.834% |
| Healthcare Services Group, Inc. | 75.21 Million USD | -41.677% |
| InnovAge Holding Corp. | 1.15 Million USD | -9133.795% |
| Assure Holdings Corp. | -19.82 Million USD | 637.52% |
| The Joint Corp. | 9.14 Million USD | -1065.623% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 201.555% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 785.055% |
| ModivCare Inc. | -26.75 Million USD | 498.348% |
| NewGenIvf Group Limited | 384.3 Thousand USD | -27627.456% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | 1921.815% |
| Option Care Health, Inc. | 376.79 Million USD | 71.72% |
| P3 Health Partners Inc. | -81.07 Million USD | 231.438% |
| P3 Health Partners Inc. | -81.07 Million USD | 231.438% |
| The Pennant Group, Inc. | 30.36 Million USD | -250.878% |
| Surgery Partners, Inc. | 446.1 Million USD | 76.113% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | 3857.485% |
| Talkspace, Inc. | -22.01 Million USD | 584.069% |
| Talkspace, Inc. | -22.01 Million USD | 584.069% |
| The Oncology Institute, Inc. | -70.45 Million USD | 251.245% |
| The Oncology Institute, Inc. | -70.45 Million USD | 251.245% |